Cardiometabolic Disorders News

Long-term use of glimepiride may improve survival and reduce hospitalizations in hospitalized patients with concomitant type 2 diabetes and chronic HF, researchers reported.

Adults with type 2 diabetes who lost at least 10% of their body weight engaged in more physical activity and slept better at 12 and 24 months than those who lost less weight, according to a study published in Diabetic Medicine.

Initiation rates of GLP-1 receptor agonists and SGLT2 inhibitors among older adults with type 2 diabetes and atherosclerotic cardiovascular disease or congestive heart failure remained low from 2016 to 2019, according to study data.

Elevated triglyceride glucose index and its dynamic change were positively associated with risk for incident hypertension among rural Chinese adults, according to research published in Nutrition, Metabolism & Cardiovascular Diseases.

A small cohort of adults with prediabetes responded favorably toward wearing flash glucose monitoring sensors for 28 days to track glucose and slow their progression toward diabetes, according to a brief report published in Diabetes Care.

The Healio and Endocrine Today Editors have compiled a list of the top endocrinology news stories from 2022.

A new clinical practice guideline from the Endocrine Society recommends treatment with IV bisphosphonates or denosumab in addition to adequate hydration for adults with moderate hypercalcemia of malignancy.

It is more appropriate to use BMI as the determinant for metabolic and bariatric surgery in treatment of type 2 diabetes.

During the past 20 years, Endocrine Today has reported on advancements in bariatric and metabolic surgery, including the evolution of the procedure and growth of high-quality clinical trial data documenting efficacy and safety.

The field of cardiology has seen stunning advances in the past several years: HF, dyslipidemia and cardiomyopathy are just three of the disorders in which there have been recent practice-changing therapeutic innovations.